Monthly Archives: February 2010

A Few Words About Diversification

Guest blog by Dr Brian White, an analyst at Shore Capital. As a result of the feared impact of the patent expiry cliff, the decimation of branded sales by multi-sourced generics and the obstacles erected, especially by managed care in the US, to slow the uptake of branded pharmaceuticals where a generic in the same […]
Posted in Europe, Global, Guest Blog, Strategy | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta